Geode Capital Management, LLC Pharma Cyte Biotech, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 200,281 shares of PMCB stock, worth $418,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200,281
Previous 215,637
7.12%
Holding current value
$418,587
Previous $465,000
1.94%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PMCB
# of Institutions
32Shares Held
1.07MCall Options Held
5.4KPut Options Held
400-
K2 Principal Fund, L.P. Toronto, A6328KShares$684,4810.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA175KShares$364,9180.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$192,4617.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$172,8990.12% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny43.8KShares$91,5420.0% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $43.4M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...